Saturday, November 23, 2024
HomeTagsNovel Antibodies

Novel Antibodies

Astellas and GO Therapeutics Enter into Strategic Research and License Agreement to Develop Novel Antibodies for Immuno-Oncology

Astellas Pharma Inc. (President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and GO Therapeutics, Inc. (Co-Founder and CEO: Constantine Theodoropulos, "GO") announced that Xyphos Biosciences,...

Twist Bioscience and Kriya Sign Agreement to Discover Novel Antibodies for Applications in Oncology Using Gene Therapy

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Kriya Therapeutics, Inc.,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics